Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses

被引:54
作者
Maldonado, R [1 ]
Valverde, O [1 ]
机构
[1] Univ Pompeu Fabra, Dept Ciencias Expt & Salut, Lab Neurofarmacol, Barcelona 08003, Spain
关键词
cannabinoid; opioid; tolerance; antinociception; anxiety; knockout;
D O I
10.1016/j.euroneuro.2003.08.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several anatomical, biochemical and pharmacological evidence support the existence of bidirectional interactions between cannabinoid and opioid systems. The present review is focused on the participation of the endogenous opioid system in the antinociceptive and emotional-like responses induced by cannabinoids, and the development of tolerance to cannabinoid pharmacological effects. Cannabinoid and opioid agonists produce antinociception by acting on similar structures within the central nervous system, and a peripheral mechanism has been also proposed for both compounds. Pharmacological studies have suggested that the endogenous opioid system could be involved in cannabinoid antinociception and the development of cannabinoid tolerance. Recent studies using knockout mice have also demonstrated the role of the opioid system in cannabinoid antinociception and tolerance, although some discrepancies with the previous pharmacological results have been reported when using knockout mice. On the other hand, cannabinoid administration can induce anxiolytic-like responses that are mediated at least in part by an endogenous opioid activity on mu- and delta-opioid receptors. (C) 2003 Elsevier B.V./ECNP. All rights reserved.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 135 条
[1]   DEVELOPMENT OF BEHAVIORAL TOLERANCE TO DELTA-9-THC WITHOUT ALTERATION OF CANNABINOID RECEPTOR-BINDING OR MESSENGER-RNA LEVELS IN WHOLE-BRAIN [J].
ABOOD, ME ;
SAUSS, C ;
FAN, F ;
TILTON, CL ;
MARTIN, BR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (03) :575-579
[2]   INTERACTION OF DELTA 9 TETRAHYDROCANNABINOL AND CANNABIDIOL ON INTESTINAL MOTILITY IN MICE [J].
ANDERSON, PF ;
JACKSON, DM ;
CHESHER, GB .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (02) :136-137
[3]   Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters [J].
Arévalo, C ;
de Miguel, R ;
Hernández-Tristán, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (01) :123-131
[4]   ENDOGENOUS PAIN CONTROL-SYSTEMS - BRAIN-STEM SPINAL PATHWAYS AND ENDORPHIN CIRCUITRY [J].
BASBAUM, AI ;
FIELDS, HL .
ANNUAL REVIEW OF NEUROSCIENCE, 1984, 7 :309-338
[5]   Time course for the induction and maintenance of tolerance to Δ9-tetrahydrocannabinol in mice [J].
Bass, CE ;
Martin, BR .
DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) :113-119
[6]   Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids [J].
Beinfeld, MC ;
Connolly, K .
NEUROSCIENCE LETTERS, 2001, 301 (01) :69-71
[7]   Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinol [J].
Berrendero, F ;
Maldonado, R .
PSYCHOPHARMACOLOGY, 2002, 163 (01) :111-117
[8]  
BICHER HI, 1968, ARCH INT PHARMACOD T, V172, P24
[9]   REDUCTION BY DELTA-9-TETRAHYDROCANNABINOL IN BLOOD-PRESSURE OF HYPERTENSIVE RATS BEARING REGENERATED ADRENAL-GLANDS [J].
BIRMINGHAM, MK .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 48 (01) :169-171
[10]   COMPARISON OF SOME PHARMACOLOGICAL ACTIONS OF MORPHINE AND DELTA-9-TETRAHYDROCANNABINOL IN MOUSE [J].
BLOOM, AS ;
DEWEY, WL .
PSYCHOPHARMACOLOGY, 1978, 57 (03) :243-248